PALOBIOFARMA, S.L.
12Patents
12Active
12Granted
50Portfolio score
Filing activity: Sep 30, 2008 → Mar 15, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10561653B2 | 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | Chemistry; Metallurgy | 9 | Active |
| US8796284B2 | 4-aminopyrimidine derivatives and their as as adenosine A2a receptor antagonists | Chemistry; Metallurgy | 6 | Active |
| US11078191B2 | 1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use thereof in the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US10933064B2 | Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts | Chemistry; Metallurgy | 1 | Active |
| US12384754B2 | Cocrystals of (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid | Chemistry; Metallurgy | 0 | Active |
| US8410282B2 | Compounds as adenosine A1 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US11654144B2 | Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts | Chemistry; Metallurgy | 0 | Active |
| US10744125B2 | Adenosine A3 receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US9447095B2 | Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10) | Chemistry; Metallurgy | 0 | Active |
| US10583127B2 | Amine salt of (1R, 3S)-3-(5-cyano-4-phenyl-1,3- thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid | Chemistry; Metallurgy | 0 | Active |
| US10253017B2 | Derivatives of 2-aminopyridine as adenosine A2B receptor antagonists and ligands of the melatonin MT3 receptors | Human Necessities | 0 | Active |
| US10238637B2 | Modulators of the adenosine A3 receptors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.